ARCHIVES

DCT Board Okays New Projects, Rejects Nutrition Research Proposal

This article is from The Cancer Letter archive.

Vol. 04 No. 43 | October 27, 1978

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

FDA Advisors Discuses Establishment of Standards for Showing Equivalence

December 17, 1999

In Brief: Chance for Rauscher Pay Increase Bill Seems Diminishing, But Schmidt Remains Confident

April 30, 1976

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004